TheZEPROJECT Catalogue

Blends · Compound profile

The KLOW Blend

KPV + GHK-Cu + BPC 157 + TB500

GLOW with an anti-inflammatory fourth component.

NF-κBCollagen genesVEGFActin
Abstract brand visual representing The KLOW Blend, a kpv + ghk-cu + bpc 157 + tb500

How The KLOW Blend works

KLOW layers KPV onto the GLOW formula. KPV damps NF-κB driven inflammatory signalling in skin and gut epithelium, so the regenerative arm of the blend works against a quieter inflammatory background — the version to reach for when irritation, not just ageing, is the limiting factor.

Reported benefits

  • Calms inflammatory skin and gut conditions
  • Full regenerative coverage from the GLOW base
  • Reduced redness and irritation during repair
  • Supports epithelial barrier integrity

Reported side effects

Effects reported in published trials, case reports or post-market surveillance. Individual response varies; this list is educational and not exhaustive.

  • Injection-site irritation and redness
  • Mild gastrointestinal upset
  • Additive uncertainty — no combination safety data

Regulatory status & sources

Not FDA approved — research use only

No regulatory approval for the blend or its individual components.

Safety note

The KLOW Blend is presented here for research and educational purposes only. It is not offered for human consumption and nothing on this page is medical advice or a dosing protocol. Read the full safety and disclaimer page.